Oligonucleotide Synthesis Market to Grow with a CAGR of 13.21% through 2030
Advancements in genomic research and RNA-based therapeutics are driving
the growth of Oligonucleotide Synthesis market in the forecast period
2026-2030.
According to TechSci Research report, “Oligonucleotide Synthesis
Market – Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2030”, the Global Oligonucleotide Synthesis Market stood
at USD 4.26 billion in 2024 and is anticipated to grow with a CAGR of 13.21 % in
the forecast period through 2030. The Oligonucleotide Synthesis market stands at
the forefront of the life sciences and biotechnology sectors, offering
essential genetic materials that underpin a wide array of applications. In
recent years, this market has experienced remarkable growth, driven by various
factors that include advancements in genomic research, the rise of RNA-based
therapeutics, and the increasing demand for precision medicine. Yet, like any
thriving industry, it faces a set of challenges and disruptions, including the
profound impact of the COVID-19 pandemic.
One of the primary
drivers of the Oligonucleotide Synthesis market is the continuous advancement
in genomic research. The decoding of entire genomes, precision medicine, and
the quest for personalized healthcare all rely heavily on oligonucleotides for
genetic analysis, molecular diagnostics, and gene editing. As researchers delve
deeper into understanding the genetic basis of diseases and the complexities of
human biology, the demand for customized oligonucleotides continues to surge.
RNA-based
therapeutics represent another significant driver. The development of messenger
RNA (mRNA) vaccines, gene therapies, and RNA interference (RNAi) treatments has
fueled the demand for tailor-made RNA molecules. Oligonucleotide synthesis
plays a pivotal role in producing high-quality, synthetic RNA sequences,
enabling these groundbreaking therapies that hold the promise of treating
various diseases with precision and efficacy. The rise of gene editing, notably
CRISPR-Cas9 technology, is yet another driving force. Researchers and biotech
companies rely on precisely engineered oligonucleotides to target specific
genetic sequences, enabling breakthroughs in genetics and biotechnology. This
transformative technology has applications in agriculture, medicine, and
various industries, driving demand for custom oligonucleotide synthesis
services. Several prominent trends are shaping the Oligonucleotide Synthesis
market. Firstly, customization and modification of oligonucleotides are on the
rise. Researchers seek chemically modified oligos to enhance stability,
specificity, and therapeutic effectiveness. This trend aligns with the
increasing adoption of precision medicine, where treatments are tailored to an
individual's genetic makeup.
Automation and
high-throughput technologies are also gaining traction. These advancements
streamline the production of oligonucleotides, reducing costs and turnaround
times. As the market grows and demand surges, the ability to efficiently scale
up production becomes paramount. Single-cell genomics is reshaping research,
with the need for specialized oligonucleotide probes and primers for studying
individual cells within complex tissues. This trend has profound implications
for cancer research, immunology, and more. In the diagnostic realm, the
development of oligonucleotide-based tests for early disease detection and
monitoring treatment responses is a growing trend. As precision medicine
becomes more prevalent, the demand for diagnostic oligonucleotides is set to rise.
While the
Oligonucleotide Synthesis market thrives, it is not without its challenges.
Cost constraints are a primary concern, especially for long or chemically
modified oligonucleotides. Achieving cost-effectiveness without compromising
quality remains an ongoing challenge for both researchers and manufacturers. Efficiency
and scalability are crucial for meeting the increasing demand for
oligonucleotides. Researchers and companies must balance efficiency in
production processes with scalability to accommodate the growing market. Stringent
regulatory requirements pose another challenge, especially in the context of
oligonucleotide-based therapeutics. Companies must navigate complex regulatory
landscapes to ensure compliance and safety. Quality control and consistency are
vital in oligonucleotide production, given their diverse applications.
Maintaining high-quality standards across batches remains a challenge.
Browse over XX market data Figures spread through XX Pages and an
in-depth TOC on
"Global Oligonucleotide Synthesis Market.”
The Global Oligonucleotide
Synthesis Market is segmented into Product Type, Application, End User, Regional Distribution, and Company.
Based on Application, The therapeutic application segment is experiencing the fastest growth within the oligonucleotide synthesis market. This surge is primarily driven by the increasing adoption of oligonucleotide-based therapies, such as antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), for treating various neurological and rare diseases. The expanding clinical pipeline of these therapies, coupled with a growing number of regulatory approvals, underscores their potential in addressing previously untreatable conditions. Additionally, the rise of personalized medicine has amplified the demand for custom oligonucleotides tailored to individual genetic profiles. Advancements in technologies like CRISPR and next-generation sequencing (NGS) further bolster the development and application of oligonucleotide-based treatments. Collectively, these factors contribute to the rapid expansion of the therapeutics segment within the oligonucleotide synthesis market.
Based on Region, The Asia Pacific region is experiencing the fastest growth in the oligonucleotide synthesis market, driven by several key factors. Rapid advancements in genomic research, coupled with the widespread adoption of technologies such as polymerase chain reaction (PCR) and sequencing, have significantly increased the demand for synthesized oligonucleotides. Countries like China, Japan, and India are making substantial investments in biotechnology and genetic research, further propelling market expansion. Additionally, the rising number of product launches and regulatory approvals in the region is fostering a conducive environment for market growth. These combined factors position Asia Pacific as a pivotal contributor to the global oligonucleotide synthesis market's expansion.
Major companies operating in Global Oligonucleotide Synthesis Market
are:
- Thermo
Fisher Scientific Inc
- Agilent Technologies,
Inc.
- Merck KGaA
- BIO-Synthesis Inc
- Eurofins Scientific SE
- Danaher Corporation
- Ajinomoto Bio-Pharma Services
- Biogen Inc.
- Ionis Pharmaceuticals,
Inc.
- Sarepta Therapeutics,
Inc.
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“The Oligonucleotide Synthesis market, driven by innovation and a surge
in genomics research and RNA-based therapies, features prominent companies such
as Integrated DNA Technologies (IDT), Eurofins Genomics, Thermo Fisher
Scientific, and Merck KGaA. These industry leaders provide a spectrum of
services, from custom oligonucleotide synthesis and modification to
high-throughput production, catering to the diverse needs of researchers and
pharmaceutical firms. With North America leading in market dominance due to its
thriving biotech ecosystem and regulatory support, these companies are at the
forefront of delivering high-quality, precise oligonucleotides critical for
genomics research, gene editing, RNA therapeutics, and diagnostic applications.
Their expertise, scalability, and commitment to innovation continue to shape
the dynamic landscape of this pivotal industry.” said Mr. Karan Chechi,
Research Director of TechSci Research, a research-based management consulting
firm.
“Oligonucleotide Synthesis
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Synthesized Oligonucleotide Products,
Reagents, Equipment, and Services), By Application (Research, Therapeutics, and
Diagnostics), By End User (Academic Research Institutes, Pharmaceutical and
Biotechnology Companies, and Hospital and Diagnostic Laboratories), By Region
and Competition, 2020-2030F”, has
evaluated the future growth potential of Global Oligonucleotide Synthesis
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Oligonucleotide
Synthesis Market.
Contact
TechSci Research LLC
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com